Additional file 3 of A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017

Additional file 3: Table S3. Age-standardized and crude rates of primary indices (and 95% uncertainty intervals) by global, socio-demographic index quintile regions, WHO regions, and 195 countries or territories. Data are taken from GBD 2017. All primary indices including prevalence, incidence, deaths, YLLs, YLDs, and DALYs are illustrated for HL, NHL, MM, leukemia, and subtypes of leukemia in 1990 and 2017. Age-standardized rates are reported per 100,000 person-years. Abbreviations: ALL = acute lymphocytic leukemia. AML = acute myeloid leukemia. CLL = chronic lymphocytic leukemia. CML = chronic myeloid leukemia. DALYs = disability-Adjusted life-years. GBD = Global Burden of Disease. HL = Hodgkin lymphoma. MM = multiple myeloma. NHL = non-Hodgkin lymphoma. SDI = Socio-demographic Index. WHO = World Health Organization. YLDs = years lived with disability. YLLs = years of life lost.

附加文件3：表S3。本表格展示了按全球、社会人口指数（SDI，Socio-demographic Index）五分位区域、世界卫生组织（WHO）区域以及195个国家或地区划分的主要指标年龄标化率与粗率（及95%不确定区间）。数据来源于2017年全球疾病负担研究（GBD，Global Burden of Disease）。本研究涵盖了1990年与2017年霍奇金淋巴瘤（HL，Hodgkin lymphoma）、非霍奇金淋巴瘤（NHL，non-Hodgkin lymphoma）、多发性骨髓瘤（MM，multiple myeloma）、白血病及其亚型的全部主要指标，包括患病率（prevalence）、发病率（incidence）、死亡数、寿命损失年（YLLs，years of life lost）、伤残损失健康寿命年（YLDs，years lived with disability）以及伤残调整寿命年（DALYs，disability-adjusted life-years）。年龄标化率以每10万人年为单位进行报告。缩略语说明：ALL（acute lymphocytic leukemia）为急性淋巴细胞白血病；AML（acute myeloid leukemia）为急性髓系白血病；CLL（chronic lymphocytic leukemia）为慢性淋巴细胞白血病；CML（chronic myeloid leukemia）为慢性髓系白血病；DALYs（disability-adjusted life-years）为伤残调整寿命年；GBD（Global Burden of Disease）为全球疾病负担研究；HL（Hodgkin lymphoma）为霍奇金淋巴瘤；MM（multiple myeloma）为多发性骨髓瘤；NHL（non-Hodgkin lymphoma）为非霍奇金淋巴瘤；SDI（Socio-demographic Index）为社会人口指数；WHO（World Health Organization）为世界卫生组织；YLDs（years lived with disability）为伤残损失健康寿命年；YLLs（years of life lost）为寿命损失年。